1. Home
  2. BATRA vs INDV Comparison

BATRA vs INDV Comparison

Compare BATRA & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

N/A

Current Price

$57.61

Market Cap

3.7B

Sector

Industrials

ML Signal

N/A

Logo Indivior PLC

INDV

Indivior PLC

N/A

Current Price

$35.62

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BATRA
INDV
Founded
2022
1994
Country
United States
United States
Employees
N/A
838
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.2B
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
BATRA
INDV
Price
$57.61
$35.62
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $49.00
AVG Volume (30 Days)
47.7K
★ 1.3M
Earning Date
11-04-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
26.00
★ 8100.00
EPS
N/A
★ 1.67
Revenue
$732,492,000.00
★ $1,239,000,000.00
Revenue This Year
$8.30
$7.50
Revenue Next Year
$5.99
$5.07
P/E Ratio
★ N/A
$21.19
Revenue Growth
★ 10.52
4.29
52 Week Low
$41.50
$22.78
52 Week High
$60.48
$42.81

Technical Indicators

Market Signals
Indicator
BATRA
INDV
Relative Strength Index (RSI) 54.01 50.10
Support Level $53.74 $35.78
Resistance Level $58.06 $36.62
Average True Range (ATR) 1.06 0.93
MACD 0.16 0.25
Stochastic Oscillator 51.28 67.98

Price Performance

Historical Comparison
BATRA
INDV

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: